PitchSend

Omnicell Investor Presentation Deck

3 Revenue Growth Drivers Deep Customer Relationships & Robust Backlog Multiple Growth Drivers © 2023 Omnicell, Inc. Strong position within the top 300 U.S. health systems Robust backlog of $1.215 Billion as of 12/31/2022 Customers increasingly turning to Omnicell for our platform-based approach to medication management Expansion opportunities within existing customer base Advanced Services expand our TAM Continued opportunities for competitive conversions 9

View entire presentation